Why BioAffinity Technologies Stock Is Popping Off
Why BioAffinity Technologies Stock Is Popping Off
BioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading higher by 80.18% to $3.82 during Wednesday's trading session after the company announced it received an additional $7.7 million from the exercise of warrants.
What Else?
BioAffinity Technologies says the company intends to use the proceeds from the offering to expand existing operations and the commercialization of CyPathLung, a noninvasive test for the early detection of lung cancer which uses flow cytometry to count and characterize cells in a person's sputum, or phlegm.
Proceeds may also be used in the company's pursuit of regulatory approvals and research and development of additional diagnostics, cancer therapeutics, and for working capital and general corporate purposes.
See Also: So What's Happening With Ocugen Stock Today?
According to data from Benzinga Pro, BioAffinity Technologies has a 52-week high of $15.55 and a 52-week low of $2.02.
BioAffinity Technologies Inc (NASDAQ:BIAF) shares are trading higher by 80.18% to $3.82 during Wednesday's trading session after the company announced it received an additional $7.7 million from the exercise of warrants.
生物親和科技公司 （納斯達克：BIAF）該公司宣布從行使認股權證中獲得額外 770 萬美元後，股票在周三交易時段上漲 80.18% 至 3.82 美元。
What Else?
還有什麼？
BioAffinity Technologies says the company intends to use the proceeds from the offering to expand existing operations and the commercialization of CyPathLung, a noninvasive test for the early detection of lung cancer which uses flow cytometry to count and characterize cells in a person's sputum, or phlegm.
生物親和技術表示，該公司打算利用該產品中的收益來擴大現有業務和 CypPath 的商業化肺，一種用於及早發現肺癌的非侵入性 test，它使用流式細胞測試來計算和表徵一個人的痰液或痰液中的細胞。
Proceeds may also be used in the company's pursuit of regulatory approvals and research and development of additional diagnostics, cancer therapeutics, and for working capital and general corporate purposes.
所得款項亦可用於公司追求監管機構批准，以及其他診斷、癌症治療的研究與開發，以及營運資金和一般企業用途。
See Also: So What's Happening With Ocugen Stock Today?
另請參閱：那麼今天 Ocugen 股票發生了什麼？
According to data from Benzinga Pro, BioAffinity Technologies has a 52-week high of $15.55 and a 52-week low of $2.02.
根據數據從本辛加臨, 生物親和力技術有 52 周高點 $15.55 和 52 周低點 $2.02.
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧